The University of Texas at San Antonio (UTSA) has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The money will go toward work at The ...

(San Antonio, September 1, 2021) The University of Texas at San Antonio (UTSA) has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The ...

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer The presence of teratoma, particularly mature teratoma, in an NSGCT primary tumor is associated with ...

Taking homegrown discoveries — research findings observed in laboratories in San Antonio — and turning them into drugs to treat disease is the focus of the Center for Innovation in Drug Discovery ...

Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent form of pancreatic cancer and presents a 5-year survival rate of less than 10%. Novel therapies focusing on targeting the tumor ...